Medicine
New study finds sleep helps clear Alzheimer's toxins from the brain
Researchers observed that normal sleep increased levels of Alzheimer's biomarkers in blood after a night's rest.
Illustration: Blue Dot News
1 min read
In a significant breakthrough, researchers Dagum P et al. have made a compelling case for the glymphatic system's role in Alzheimer's disease (AD) pathophysiology. The glymphatic system, responsible for clearing waste from the brain, has been proposed as a mechanistic link between sleep disruption and AD.
A randomized crossover trial with 39 participants was conducted to investigate whether the glymphatic system clears amyloid beta (Aβ) and tau in humans. Participants underwent overnight monitoring using an investigational device that measured dynamic changes in synaptic-metabolic release and glymphatic activity. The results showed that glymphatic clearance during normal sleep increased morning plasma levels of AD biomarkers compared to sleep deprivation.
This finding is supported by a multicompartment model based on published data on Aβ and tau release and clearance. The observed changes mirrored predictions from this model, suggesting a key role for glymphatic function in AD pathophysiology. Furthermore, the study indicates that sleep-active physiological processes enhance overnight glymphatic clearance of AD biomarkers to plasma.
The significance of this discovery lies not only in its implications for AD disease progression but also in its broader relevance to our understanding of the human brain's waste management systems. The glymphatic system's ability to clear waste under normal sleep conditions has profound implications for our daily lives, highlighting the intricate relationships between our physiological processes and the universe around us.
1 min read
In the quiet hours of night, our brains work tirelessly to clear away the waste that builds up and harms us. A team of researchers has been studying this process, known as glymphatic clearance, and what they've found is both surprising and promising.
It turns out that when we sleep, our bodies are able to remove more toxins from our brains than when we're awake. This is especially important for people with Alzheimer's disease, a condition where the buildup of certain proteins in the brain can lead to memory loss and other problems. In animal models, it's already been shown that glymphatic impairment can drive this kind of pathology. But what about humans? Can our bodies do the same thing?
The answer is yes. A recent study found that when participants got enough sleep, their brains were able to clear away more of these toxins than when they were awake and tired. This means that getting a good night's sleep might be an important part of slowing down Alzheimer's disease - and it all comes down to the way our bodies work during those quiet hours at night.
1 min read
Imagine your brain is like a house with streets that clean up trash and debris every night while you sleep. This process, called the glymphatic system, helps get rid of the bad stuff that can make Alzheimer's disease worse. For a long time, scientists didn't know if this system worked in humans or not.
But now, researchers have discovered that when we get enough restful sleep, our brain's cleaning system works better and clears out more of the bad stuff called amyloid beta and tau from our brains to the bloodstream. This is good news because it means that we might be able to slow down Alzheimer's disease by helping our brain's cleaning system work properly. The scientists who did this research found that when people got enough sleep, their brains cleaned up more of the bad stuff at night, which helped reduce the amount in their blood.
The people behind the work
-
Dagum P et al.
Author
Published in Nature communications
Source: Nature communications
Sources & Verification
Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.
- Dysfunction of the glymphatic system has been proposed as a mechanistic link between sleep disruption and Alzheimer's disease (AD). Nature communications
- In animal models, glymphatic impairment alone can drive AD pathology. Nature communications
- Whether this system clears amyloid beta (Aβ) and tau in humans remains unknown. Nature communications
- In a randomized crossover trial with 39 participants, we found that glymphatic clearance during normal sleep increased morning plasma levels of AD biomarkers compared to sleep deprivation. Nature communications
- Participants underwent overnight monitoring using an investigational device that measured dynamic changes in synaptic-metabolic release and glymphatic activity. Nature communications
- The observed changes mirrored predictions from a multicompartment model based on published data on Aβ and tau release and clearance. Nature communications
- Our findings indicate that sleep-active physiological processes, particularly reduced brain parenchymal resistance, enhance overnight glymphatic clearance of AD biomarkers to plasma. Nature communications
- These results support a key role for glymphatic function in AD pathophysiology and suggest its enhancement as a potential therapeutic strategy to slow disease progression. Nature communications
Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.